A mple posterior fossa craniectomy with augmentative duraplasty is a widely accepted procedure in the surgical management of symptomatic patients with Chiari malformation Type I (CM-I). 25 The keys to the success of cerebral operative procedures are to create ample decompression, regain normal CSF flow, and achieve effective watertight dural closure. 7, 19, 20 There are many methods for further expansion of the posterior fossa during duraplasty. A dural graft should be used when a sufficient amount of the autogenous dura mater is not available after decompression. The ideal graft should generally be nonimmunogenic, nontoxic, rapidly integrated into native tissues, flexible, strong, easily suturable, and readily available. The graft should not cause inflammatory reactions or adhesions and should be able to be closed in a watertight fashion. 5,6,11, 23 Allografts, xenografts, and synthetic dural substitutes are used for duraplasty, but all of these types of graft are associated with high complication rates.
our technique and the results of its application in 27 cases in our clinical center. To the best of our knowledge, this is the first report of the application of this technique.
Methods

Patients
Between 2011 and 2014, 31 patients who were preoperatively diagnosed with symptomatic CM-I underwent suboccipital decompression and either duraplasty in situ or synthetic dural graft duraplasty, which were performed by the senior surgeon (L.L.) who invented the duraplasty in situ technique at our institution. Of these patients, 3 treated with suboccipital decompression alone were excluded from the analysis, and 1 did not undergo a follow-up after discharge from the hospital. Among the remaining patients, 13 (3 men, 10 women) underwent surgery using the new technique, duraplasty in situ, and 14 (6 men, 8 women) underwent surgery using duraplasty in which a synthetic dural graft was placed. All data were retrospectively collected to evaluate this technique, including demographic data (age and sex), body mass index (BMI), preoperative symptom status, overall operative time, estimated blood loss (EBL), length of hospital stay (LOS) after the operation, hospital cost, and complications. CM-I was diagnosed clinically based on symptoms and radiologically based on preoperative MRI studies. All patients provided informed consent and were requested to return for follow-up in the outpatient department. Routine MRI scans were obtained 2 weeks and 6 months after surgery in all patients. We used neurological outcome and syrinx size on postoperative MRI to establish functional status at 6 months after surgery. The total hospital cost for each patient was calculated as the sum of the surgical, hospital, examination, and allied service costs.
operative technique
The patient was placed prone with the head flexed and secured in Mayfield pins after general anesthesia was administered. A suboccipital midline incision of 5 cm was made from the inion to the expected caudal extent of the decompression (Fig. 1A) . The paraspinous musculature was separated along the avascular midline using self-retaining retractors. The foramen magnum, C-1 lamina, and C-2 spinous process were exposed, and an occipital craniectomy was performed (Fig. 1B) . A bony decompression window (3 × 3 cm) was created using a high-speed cutting drill and rongeur forceps (Fig. 1C ). An approximately 2-cm-wide portion of the C-1 arch was removed, and the superior margin of the C-2 arch was partially removed in the rare cases in which the tonsillar herniation extended to the C-2 level (Fig. 1D ). The technique is performed using the operating microscope; a 5× magnification is applied for a clear view of the operative site. Consequently, the outer layer of the dura was cut in a U-shaped fashion from the bottom of the C-2 arch ( Fig. 2A) . The edge of the outer layer of the dura was elevated and gradually separated from the inner layer of the dura upwards using delicate dissection until the decompressive bony margin on the surface of the cerebellar hemispheres was reached (Fig. 2B) ; we were careful to separate the dura through the natural space between the layers. If the 2 layers are difficult to separate, especially in older patients, one should begin with the easier part first and then deal with the more tightly adhered part. Small holes made in the dura during separation can be sutured with Prolene. Any bleeding between the 2 layers was resolved with cottonoid pressure, and in cases of dural shrinkage, bipolar coagulation was used as minimally as possible at the lowest intensity. Finally, a ligulate outer-layer dural flap was created. The inner layer of the dura was opened in a Y-shaped fashion while attempting to keep the arachnoid membrane intact (Fig. 2C and D) . The ligulate outer-layer dural flap was deflected down and sutured to the Y-shaped margin of the inner layer using running sutures ( Fig. 3A and B) . Using this technique, the ligulate outer-layer dural flap was enlarged for augmentative duraplasty (Fig. 3C ). Hemostasis was meticulously achieved, and a drainage tube was placed. Then, the surgical wound was closed in multiple layers.
statistical analysis
Categorical data were analyzed using Pearson's chisquare test. Continuous data were analyzed using the Student t-test. All analyses were performed with SPSS 22.0 software (IBM Corp.). A p value < 0.05 was considered significant. Mean values are presented ± SD.
results
Of the 31 patients initially considered for enrollment in this study, 3 underwent decompression without opening of the dura and 1 did not complete follow-up. Thus, 27 patients completed follow-up, and their data were included in the analyses. The demographic and clinical data are presented in Table 1 . In the duraplasty in situ group, the mean age of the patients was 40 ± 15 years (range 11-59 years) and the mean BMI was 23.3 ± 5.3 kg/m 2 (range 14.8-33.8 kg/m 2 ). In the synthetic dural graft duraplasty group, the mean age was 34 ± 13 years (range 13-56 years) and the mean BMI was 23.3 ± 4.1 kg/m 2 (range 18.5-33.8 kg/m 2 ). All patients underwent a full neurological examination. Brachial neuralgia, motor weakness, paresthesia, headaches, vomiting, scoliosis, and hoarseness were observed. Motor weakness was the most common symptom in both groups. Clinical characteristics and outcome details are listed in Table 2 .
A comparison of the perioperative details is shown in Table 3 . The mean overall operative time for the duraplasty in situ group was 4.9 ± 1 hours (range 3.5-7.0 hours) compared with 4.1 ± 1 hours (range 2.5-5.5 hours) for the synthetic dural graft duraplasty group. The mean EBL was 229 ± 176 ml (range 30-600 ml) in the duraplasty in situ group compared with 254 ± 82 ml (range 50-300 ml) in the synthetic dural graft duraplasty group. The mean LOS after the operation was 13.5 ± 8.2 days (range 7-37 days) in the duraplasty in situ group compared with 12.8 ± 6.0 days (range 6-30 days) in the synthetic dural graft duraplasty group. The hospital cost was higher in the synthetic dural graft duraplasty group than in the duraplasty in situ group, and this difference was significant (mean CNY 29,385 vs CNY 23,354; p < 0.05; CNY 1 = US$0.16).
No surgical mortality or neurological aggravation occurred postoperatively. Fewer complications were encountered in the duraplasty in situ group than in the synthetic dural graft duraplasty group. In the in situ group, 1 patient had a fever on postoperative Day 8 and was diagnosed with bacterial meningitis after lumbar puncture. He was treated with antibiotics for 2 weeks and was discharged after his symptoms resolved and his laboratory test results were negative. One patient in the synthetic dural graft group was also diagnosed with meningitis. This patient was treated by the same method and recovered in 4 days. Another patient in the synthetic dural graft group experienced a CSF leak. The leak was small, and it ceased spontaneously within 5 days without any neurological consequences. Pseudomeningocele or surgical-site infection did not occur in either group. All patients were followed up in the outpatient clinic. In the duraplasty in situ group, neurological outcome improved in 11 of the 13 patients (84.6%) and stabilized in 2 (15.4%); none of the patients became worse. In the synthetic dural graft duraplasty group, 12 of the 14 patients (85.7%) improved, 1 (7.1%) remained stable, and 1 (7.1%) grew worse. In the duraplasty in situ patients, MRI showed that syrinx size had improved in 4 of the 10 patients (40%) and stabilized in 6 (60%). In the synthetic dural graft duraplasty group, syrinx size improved in 8 of 14 patients (57.1%) and remained stable in 6 (42.9%). Grafting was successful in all patients in the synthetic dural graft duraplasty group. MRI data showed total decompression of the posterior fossa in all patients in both groups (Fig. 4) . All 27 patients demonstrated improvement of preoperative symptoms and good wound healing.
Discussion
Here, we report a novel autologous duraplasty in situ technique for the treatment of CM-I. To our knowledge, this is the first study to describe the application of this procedure. The results of this study demonstrate that this novel procedure is comparable to synthetic dural graft duraplasty; moreover, its associated hospital costs were significantly lower than those of synthetic dural graft duraplasty.
Posterior fossa decompression is the standard surgical procedure for patients with CM-I. The dura is often expanded to allow further expansion of the posterior fossa. The creation of a watertight dural repair reduces the risk of CSF leakage.
8,10,12,17 There is still significant controversy regarding the most appropriate duraplasty method. Duraplasty can be performed using autologous tissues or commercially available dural patches. 3, 6 Nonautogenous grafts are easy to acquire but are associated with a wide range of complications including hemorrhage, transmission of bacterial and viral pathogens, fatal Creutzfeldt-Jakob disease transmission, foreign body reaction, systemic immune response, excessive scarring, slower wound healing, premature graft dissolution, and wound dehiscence. Agg = aggravated; DIS = duraplasty in situ; Imp = improved; SDGD = synthetic dural graft duraplasty; Stable = stabilized; Tx = treatment.
In addition, they are associated with a high incidence of persistent CSF leaks, pseudomeningocele formation, aseptic meningitis, infection, and hydrocephalus. 7, 11, 15, 16 The limitations of the use of autologous tissues, such as autologous fascia lata, ligamentum nuchae, fat packings, and the pericranium, include the time-consuming nature of procedures using such tissues, harvest-site complications, insufficient tissue availability, and technical difficulty.
11, 13, 19 Obtaining sufficient autogenous tissue requires a longer incision or a second incision, which is associated with pain and scarring. The formation of a long occipital incision increases the risk of injury to the occipital artery and the greater occipital nerves. 23, 24 Although the literature does not strongly support the superiority of either autologous or nonautologous grafts, autologous tissue is recommended by many neurosurgeons when it is available and of good quality.
1 Compared with the traditional duraplasty procedure, duraplasty in situ does not use nonautologous grafts and does not require an additional incision. Therefore, it is the least invasive technique for autologous duraplasty that has been developed so far. The results of this analysis demonstrate no significant differences between the 2 groups in overall operative time, complications, estimated blood loss, or duration of hospital stay after the operation. Based on our experience, we believe that our new procedure is as sufficient and safe as duraplasty with a synthetic dural graft.
The key to the success of this procedure is the separation of the outer and inner layers of the dura because the inner layer is much thinner than the outer layer and small vessels are distributed between these 2 layers. Therefore, the inner layer of the dura mater could be torn, causing bleeding. Overuse of bipolar coagulation may cause shrinkage of the dura. If the 2 layers are hard to separate or shrinkage of the dura makes suturing impossible, the procedure can be switched to one that involves a synthetic dural graft. According to our experience, a senior doctor can master this technique after approximately 5 to 7 cases. Consistent with our experience, Isu et al. reported good outcomes with their technique of bony foramen magnum decompression combined with removal of the outer layer of the dura mater. In China, artificial dural grafts account for a considerable proportion of hospital costs and are not yet fully covered by medical insurance. The results of our study demonstrate that this new procedure significantly reduces cost. Thus, patients who have economic difficulties will benefit from the cost-effectiveness of this procedure and be able to undergo the operation sooner. We believe this procedure is worth promoting, especially in developing countries.
The study is limited by several factors. First, the perfor- mance of this procedure by only 1 surgeon may introduce doubt regarding its repeatability; however, the use of a single surgeon also eliminated bias due to differences in surgeon expertise. Second, the size of our sample was small. The major limitation was the single-center retrospective design and the absence of long-term follow-up. These issues need to be resolved in future studies.
